A clinical trial to study the effects of two different practices of peripheral IV catheter insertion on incidence of local site infections / inflammatio
- Conditions
- Health Condition 1: null- Patients listed for elective surgical operations in operation theatres of hospital
- Registration Number
- CTRI/2018/01/011104
- Lead Sponsor
- Armed Forces Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 357
1.)One hundred patients in whom intravenous catheter insertion be carried out by the researcher himself will be included in the study. They will be followed up till catheter removal OR up till 72 hours of catheter insertion whichever is earlier.
2.)Only patients with ASA Status I, II & III undergoing elective surgery will be enrolled.
3.)To remove study bias arising due to gender only male volunteers will be recruited in the study.
4.)Individuals with age between 20 years to 60 years will be included in the study.
5.)Individuals with cannula inserted in upper extremities only will be included in the study.
1.)ASA Status IV, V and those requiring emergency surgery/ intervention.
2.) Patients enlisted for day care surgery or on OPD based anesthetic requirement.
3.)Immunocompromised patients.
4.)Patients on any chemotherapy for malignancy.
5.)Patients diagnosed as sepsis syndrome.
6.)Patients in whom I.V. catheters were indicated for less than 24 hours.
7.)Patients requiring blood transfusions from same cannulas.
8.)If more than 2 attempts are taken at insertion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method During withdrawal, the duration for which the cannula remained in situ will be calculated along with the condition of the patient and presence of any signs of thrombophlebitis.Timepoint: Max 72 hours observation or at time of catheter removal, whichever is earlier. During withdrawal, the duration for which the cannula remained in situ will be calculated along with the condition of the patient and presence of any signs of thrombophlebitis.
- Secondary Outcome Measures
Name Time Method Other Points noted will be the number of attempts taken at insertion, site of insertion, guage of catheter used and the type of procedure followed during insertion.Timepoint: maximum 72 hours or at time of catheter removal, whichever is earlier. Other Points noted will be the number of attempts taken at insertion, site of insertion, guage of catheter used and the type of procedure followed during insertion.